Clinical Trial Supply is like an entire Galaxy with Ryan Keane

Transformation in Trials

Send us a text

How is the pharmaceutical and biotech industry changing in the current financial climate? Our guest today, Ryan Keane, founder and CEO of Korio, shines a bright light on these subjects and more. This discussion is an exploration of our current healthcare landscape, dissecting the challenges companies face as they introduce new technology, the sudden shift in the vendor landscape, and the unexpected destruction of value in biotech due to companies discarding or divesting their assets.
We don't just stop at the surface. Ryan takes us deep into the complexities of customizing Interactive Response Technology (IRT) systems in clinical trials, highlighting the crucial role of education for both buyers and industry employees. We tackle the challenges of communicating complex information to patients and the need for creating reproducible and scalable processes. The conversation veers into the often misunderstood realm of clinical trial supply, the need for a no-code environment, and the importance of having technologically savvy folks who comprehend all the elements.
Guest:
Ryan Keane

________
Reach out to Sam Parnell and Ivanna Rosendal
Join the conversation on our LinkedIn page

Chapitres

1. Clinical Trial Supply is like an entire Galaxy with Ryan Keane (00:00:00)

2. The State of Pharma and Biotech (00:00:21)

3. The Challenges of Customizing IRT Systems (00:15:04)

4. Challenges and Integration in Clinical Trials (00:25:23)